Save time and get answers to complex questions with AI chat
Patent expiration date of guselkumab?Quartette side effects?Drugpatentwatch crizotinib?Novartis patent term dabrafenib?Pramlintide approval date?
See the DrugPatentWatch profile for kyzatrex
The wholesale acquisition cost (WAC) price for Marius Pharmaceuticals' KYZATREX (testosterone undecanoate) is \$587.40 for a 30-count bottle of 40 mg capsules [1].
The patent exclusivity for KYZATREX, manufactured by Marius Pharmaceuticals, is set to expire in 2036 [2]. This patent information can be tracked through resources like DrugPatentWatch.com [2].
KYZATREX is an oral formulation of testosterone undecanoate [3]. It is designed to increase testosterone levels in men diagnosed with hypogonadism, commonly known as low testosterone [3]. The drug works by delivering testosterone to the body through absorption in the gastrointestinal tract [3].
KYZATREX is approved for the treatment of low testosterone in adult men [3]. It is indicated for men diagnosed with hypogonadism due to a deficiency of endogenous testosterone [3].
Other Questions About Kyzatrex :